HOME
LOGIN
THE MEDICAL LETTER
Subscribe
Current Issue
Previous Issues
Reference Tables
Sample Articles
ABOUT US
The Medical Letter, Inc.
CONTINUING EDUCATION
Exams
DRUG INTERACTIONS
PRODUCTS
CONTACT US
The Medical Letter Mobile Home Page
CURRENT
ISSUE
1619
The FDA has approved an oral tablet formulation of sodium sulfate, magnesium sulfate, and potassium chloride (Sutab – Braintree) for colon cleansing prior to colonoscopy in adults. A sodium sulfate-based oral solution (Suprep) has been available in the US since 2010. Sutab is the second tablet formulation to be approved for bowel cleansing prior to colonoscopy; a sodium phosphate-based tablet (OsmoPrep) was approved...  read more...
More from issue 1619
Advance Release
Coming Soon
Low-Dose Colchicine for Coronary Artery Disease
Drugs for Multiple Sclerosis
Semaglutide (Ozempic) for Weight Loss
In Brief: Hypertension with Erenumab (Aimovig)
Recommend to Your Library  
Previous Issues
© 2021 The Medical Letter, Inc.